205 related articles for article (PubMed ID: 17988417)
1. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
Schilt T; de Win MM; Jager G; Koeter MW; Ramsey NF; Schmand B; van den Brink W
Psychol Med; 2008 Sep; 38(9):1309-17. PubMed ID: 17988417
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
[TBL] [Abstract][Full Text] [Related]
3. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
Morgan MJ; McFie L; Fleetwood H; Robinson JA
Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
[TBL] [Abstract][Full Text] [Related]
4. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
Fox HC; Parrott AC; Turner JJ
J Psychopharmacol; 2001 Dec; 15(4):273-81. PubMed ID: 11769821
[TBL] [Abstract][Full Text] [Related]
5. Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users.
Parrott A
Hum Psychopharmacol; 2003 Mar; 18(2):89-90. PubMed ID: 12590401
[No Abstract] [Full Text] [Related]
6. Memory deficits associated with recreational use of "ecstasy" (MDMA).
Morgan MJ
Psychopharmacology (Berl); 1999 Jan; 141(1):30-6. PubMed ID: 9952062
[TBL] [Abstract][Full Text] [Related]
7. Cognitive performance amongst recreational users of "ecstasy".
Rodgers J
Psychopharmacology (Berl); 2000 Jul; 151(1):19-24. PubMed ID: 10958112
[TBL] [Abstract][Full Text] [Related]
8. The health effects of ecstasy: a literature review.
Gowing LR; Henry-Edwards SM; Irvine RJ; Ali RL
Drug Alcohol Rev; 2002 Mar; 21(1):53-63. PubMed ID: 12189005
[TBL] [Abstract][Full Text] [Related]
9. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA).
Gouzoulis-Mayfrank E; Daumann J; Tuchtenhagen F; Pelz S; Becker S; Kunert HJ; Fimm B; Sass H
J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):719-25. PubMed ID: 10811694
[TBL] [Abstract][Full Text] [Related]
10. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.
Thomasius R; Petersen K; Buchert R; Andresen B; Zapletalova P; Wartberg L; Nebeling B; Schmoldt A
Psychopharmacology (Berl); 2003 Apr; 167(1):85-96. PubMed ID: 12632248
[TBL] [Abstract][Full Text] [Related]
11. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
Parrott AC; Milani RM; Parmar R; Turner JD
Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
[TBL] [Abstract][Full Text] [Related]
12. Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment.
Bhattachary S; Powell JH
Psychol Med; 2001 May; 31(4):647-58. PubMed ID: 11352367
[TBL] [Abstract][Full Text] [Related]
13. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.
Parrott AC; Lasky J
Psychopharmacology (Berl); 1998 Oct; 139(3):261-8. PubMed ID: 9784083
[TBL] [Abstract][Full Text] [Related]
14. Is the use of ecstasy and hallucinogens increasing? Results from a community study.
Schuster P; Lieb R; Lamertz C; Wittchen HU
Eur Addict Res; 1998 Mar; 4(1-2):75-82. PubMed ID: 9740820
[TBL] [Abstract][Full Text] [Related]
15. Intellectual and neuropsychological functions in young men with heavy and long-term patterns of drug abuse.
Bruhn P; Maage N
Am J Psychiatry; 1975 Apr; 132(4):397-401. PubMed ID: 1119590
[TBL] [Abstract][Full Text] [Related]
16. Adverse effects of stimulant drugs in a community sample of drug users.
Williamson S; Gossop M; Powis B; Griffiths P; Fountain J; Strang J
Drug Alcohol Depend; 1997 Mar; 44(2-3):87-94. PubMed ID: 9088780
[TBL] [Abstract][Full Text] [Related]
17. N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study.
Cowan RL; Joers JM; Dietrich MS
Pharmacol Biochem Behav; 2009 Mar; 92(1):105-10. PubMed ID: 19032963
[TBL] [Abstract][Full Text] [Related]
18. Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users.
Parrott AC; Sisk E; Turner JJ
Drug Alcohol Depend; 2000 Jul; 60(1):105-10. PubMed ID: 10821995
[TBL] [Abstract][Full Text] [Related]
19. The impact of regular ecstasy use on memory function.
Simon NG; Mattick RP
Addiction; 2002 Dec; 97(12):1523-9. PubMed ID: 12472636
[TBL] [Abstract][Full Text] [Related]
20. Incidental use of ecstasy: no evidence for harmful effects on cognitive brain function in a prospective fMRI study.
Jager G; de Win MM; Vervaeke HK; Schilt T; Kahn RS; van den Brink W; van Ree JM; Ramsey NF
Psychopharmacology (Berl); 2007 Aug; 193(3):403-14. PubMed ID: 17476480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
